Global Markets
Home›Global Markets›Europe›Nanexa shares jump more than 150% after licensing deal…
Nanexa shares jump more than 150% after licensing deal with Novo Nordisk
Nanexa, a Swedish microcap drug-delivery company, saw its shares more than double after disclosing a licensing deal with European pharma giant Novo Nordisk, CNBC World reports.
The announcement drove the stock surge to more than 150% as investors reacted to the new injectables-related partnership.
← Newer storyTalkTalk nears deals to sell assets to avoid administrationOlder story →Researchers publish Zcash-style design for private Bitcoin transfers
More like this
Global MarketsHealey appoints Ravinder Athwal as senior adviser